Literature DB >> 29587220

The purinergic P2X7 ion channel receptor-a 'repair' receptor in bone.

Niklas Rye Jørgensen1.   

Abstract

A strong skeleton relies on adaptation to varying physical demands and on maintenance of the bone tissue in order to avoid accumulation of micro-damage. In bone, the purinergic P2X7 ion channel receptor is expressed on both cells of the stromal lineage such as the bone forming osteoblasts and the mechano-sensing osteocytes and on cells belonging to the immune-related monocyte-macrophage lineage, the bone resorbing osteoclasts. Recent studies have demonstrated that the receptor plays important roles in the anabolic responses to mechanical loading on bone and, together with the pannexin1 hemi-channel, in the process of initiating bone remodeling in response to micro-damage. Thus, the receptor is crucial in skeletal mechano-transduction and in the continuous repair process. However, under pathophysiological conditions such as diabetes with high glucose concentrations or glucocorticoid-treatment the receptor is downregulated thus blunting the important effects it has for maintaining a healthy and strong skeleton.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29587220     DOI: 10.1016/j.coi.2018.03.016

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  8 in total

1.  New insights into P2X7 receptor regulation: Ca2+-calmodulin and GDP bind to the soluble P2X7 ballast domain.

Authors:  Simon Sander; Isabel Müller; Maria Garcia Alai; Annette Nicke; Henning Tidow
Journal:  J Biol Chem       Date:  2022-09-14       Impact factor: 5.486

Review 2.  Osteocytes and Diabetes: Altered Function of Diabetic Osteocytes.

Authors:  Arancha R Gortázar; Juan A Ardura
Journal:  Curr Osteoporos Rep       Date:  2020-11-13       Impact factor: 5.096

3.  Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling.

Authors:  Yonggang Ma; Xueni Shi; Hongyan Zhao; Ruilong Song; Hui Zou; Jiaqiao Zhu; Zongping Liu
Journal:  Int J Mol Med       Date:  2022-03-10       Impact factor: 4.101

Review 4.  Extracellular ATP and its derivatives provide spatiotemporal guidance for bone adaptation to wide spectrum of physical forces.

Authors:  Chrisanne Dsouza; Mahmoud S Moussa; Nicholas Mikolajewicz; Svetlana V Komarova
Journal:  Bone Rep       Date:  2022-08-01

5.  Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway.

Authors:  Camilo Morales-Jiménez; Julián Balanta-Melo; Manuel Arias-Calderón; Nadia Hernández; Fernán Gómez-Valenzuela; Alejandro Escobar; Enrique Jaimovich; Sonja Buvinic
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

6.  IRE1-mTOR-PERK Axis Coordinates Autophagy and ER Stress-Apoptosis Induced by P2X7-Mediated Ca2+ Influx in Osteoarthritis.

Authors:  Zihao Li; Ziyu Huang; He Zhang; Jinghan Lu; Yingliang Wei; Yue Yang; Lunhao Bai
Journal:  Front Cell Dev Biol       Date:  2021-06-17

7.  Electromagnetic field treatment increases purinergic receptor P2X7 expression and activates its downstream Akt/GSK3β/β-catenin axis in mesenchymal stem cells under osteogenic induction.

Authors:  Yingchi Zhang; Wenkai Li; Chaoxu Liu; Jiyuan Yan; Xuefeng Yuan; Wei Wang; Huaixi Wang; Hua Wu; Yong Yang
Journal:  Stem Cell Res Ther       Date:  2019-12-21       Impact factor: 6.832

Review 8.  Structural basis for the functional properties of the P2X7 receptor for extracellular ATP.

Authors:  Lin-Hua Jiang; Emily A Caseley; Steve P Muench; Sébastien Roger
Journal:  Purinergic Signal       Date:  2021-05-13       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.